14-03-2025 15:37 via medpagetoday.com

Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

(MedPage Today) -- SAN FRANCISCO--A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre...
Read more »

Medical news



Long-Acting ART Could Prevent More Infant HIV Infections in Zimbabwe
Mixed Results for Therapeutic Candidates for Platinum-Resistant Ovarian Cancer
'People in Medicine Feel Very Threatened Right Now': What We Heard This Week
Add-On Metformin Promising in ER-Positive Endometrial Cancer
DIY Healthcare Can Help Counter the Physician Shortage
Study Suggests Higher Odds of Congenital Syphilis With 9-Day Treatment Interval
No Benefit With CRT Versus RT in Cervical Cancer After Radical Hysterectomy
Why Did Doctors Sue HHS?
Income, Education, and CVD; Maternal Death Worldwide
Pembrolizumab-CRT: The New Standard of Care in Locally Advanced Cervical Cancer?
Can Both Sides of the Aisle Rally Around Better Health?
Inside the Government Study Looking at the Health Effects of Ultraprocessed Foods
Probiotics Cut Fever Duration in Kids With Upper Respiratory Infections
Therapy Dogs Cut Anxiety for Children in the ED
Desktop versie